Know Cancer

or
forgot password

INST 0817: Compassionate Use of Mifepristone


N/A
18 Years
N/A
Open (Enrolling by invite only)
Both
Cancer

Thank you

Trial Information

INST 0817: Compassionate Use of Mifepristone


This is a compassionate use of mifepristone treatment for patients with conditions that
could respond to an antiprogesterone agent, including:

- Meningioma.

- Breast cancer

- Colon Cancer

- Endometrial Stromal Sarcoma

- Bilateral Chronic Central Serous Retinopathy

- Cushing's Syndrome

- Metastatic Adrenocortical Cancer

- Ovarian Cancer

- Other conditions as determined by the attending physicians


Inclusion Criteria:



- All patients 18 years of age or older.

- Patients must sign an informed consent.

- Patients should be in such a health condition in the opinion of the attending
physician that with the administration of mifepristone benefits may outweigh risks.

Exclusion Criteria:

- Pregnant women or nursing mothers are not eligible for this trial. Patients of child
bearing potential must use adequate contraception.

Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention

Outcome Measure:

Time to progression

Outcome Time Frame:

5 months or longer

Safety Issue:

No

Principal Investigator

Fa-Chyi Lee, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of New Mexico Cancer Center

Authority:

United States: Food and Drug Administration

Study ID:

INST 0817

NCT ID:

NCT00832871

Start Date:

November 2008

Completion Date:

December 2014

Related Keywords:

  • Cancer
  • Mifepristone
  • RU-486
  • Compassionate Use
  • Antiprogesterone

Name

Location

Universtiy of New Mexico - Cancer CenterAlbuquerque, New Mexico  87106